Managed Account Advisors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Managed Account Advisors’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$200K	Buy	+12,695	New	+$154K	﹤0.01%	2482

Other funds holding RPTP

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Managed Account Advisors's RPTP Position: Q2 2015 in Review

Managed Account Advisors opened a new position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2015: 12,695 shares worth $200K. The stake represents ﹤0.01% of the portfolio and ranks #2482 among its holdings.

100 funds tracked by Wall St. Rank hold RPTP as of Q2 2015.

Managed Account Advisors held 12,695 shares of RAPTOR PHARMACEUTICAL CORP COM STK (DE) worth $200K as of Q2 2015.
RAPTOR PHARMACEUTICAL CORP COM STK (DE) was a new Managed Account Advisors position in Q2 2015.
RAPTOR PHARMACEUTICAL CORP COM STK (DE) made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2482 holding.
100 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.